Categories

Tags

Emerging Technologies II

Emerging Technologies II
Date
June 23, 2021
Co-Chairs
Jason S. Carroll, PhD
Cancer Research UK, University of Cambridge
Russell W. Jenkins, MD, PhD
Massachusetts General Hospital
Driving Precision Medicine through Clinical Computational Oncology
Date
June 23, 2021
Speaker
Priti Hegde, PhD
Foundation Medicine
Organotypic Modeling of Cancer and Immune Cell Dynamics
Date
June 23, 2021
Speaker
Russell W. Jenkins, MD, PhD
Massachusetts General Hospital
Inferring and Making Sense Out of Cancer Cell Phylogenies
Date
June 23, 2021
Speaker
Nir Yosef, PhD
University of California, Berkeley
Targeted Protein Degradation- A New Approach for Challenging Targets
Date
June 23, 2021
Speaker
Nathanael Gray, PhD
Stanford University
Short Talk: MLL-Menin Inhibition Reverses Pre-leukemic Progenitor Self-renewal in NPM1 Mutant AML
Date
June 23, 2021
Speaker
Hannah J. Uckelmann, PhD
Dana-Farber Cancer Institute

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.